BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36296520)

  • 1. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
    Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents.
    Acar Çevik U; Celik I; Paşayeva L; Fatullayev H; Bostancı HE; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200663. PubMed ID: 36760015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations.
    Khan S; Iqbal S; Rahim F; Shah M; Hussain R; Alrbyawi H; Rehman W; Dera AA; Rasheed L; Somaily HH; Pashameah RA; Alzahrani E; Farouk AE
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico and in vitro studies of thiosemicarbazone-indole hybrid compounds as potent α-glycosidase inhibitors.
    Bakherad Z; Bakherad H; Sepehri S; Faramarzi MA; Mahnam K; Mojtabavi S; Mahdavi M
    Comput Biol Chem; 2022 Apr; 97():107642. PubMed ID: 35183819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
    Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
    Molecules; 2023 May; 28(10):. PubMed ID: 37241920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies.
    Mukhtar A; Shah S; Kanwal ; Hameed S; Khan KM; Khan SU; Zaib S; Iqbal J; Perveen S
    Med Chem; 2021; 17(8):887-902. PubMed ID: 32851965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
    Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
    J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.
    Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
    Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
    Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies.
    Zareei S; Ranjbar S; Mohammadi M; Ghasemi Y; Golestanian S; Avizheh L; Moazzam A; Larijani B; Mohammadi-Khanaposhtani M; Tarahomi MM; Mahdavi M; Sadeghian N; Taslimi P
    Bioorg Chem; 2023 Dec; 141():106846. PubMed ID: 37713948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors.
    Basri R; Ullah S; Khan A; Mali SN; Abchir O; Chtita S; El-Gokha A; Taslimi P; Binsaleh AY; El-Kott AF; Al-Harrasi A; Shafiq Z
    Bioorg Chem; 2023 Oct; 139():106739. PubMed ID: 37478545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro α-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents.
    Shayegan N; Haghipour S; Tanideh N; Moazzam A; Mojtabavi S; Faramarzi MA; Irajie C; Parizad S; Ansari S; Larijani B; Hosseini S; Iraji A; Mahdavi M
    Sci Rep; 2023 Apr; 13(1):6304. PubMed ID: 37072431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
    Hameed S; Kanwal ; Seraj F; Rafique R; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Salar U; Taha M; Khan KM
    Eur J Med Chem; 2019 Dec; 183():111677. PubMed ID: 31514061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
    Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
    Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.